novo nordisk weight loss - Search News

News

Shares in Novo Nordisk Lost Weight Today

The Motley Fool on MSN · 1h

Why Shares in Novo Nordisk Lost Weight Today

Shares in Denmark's pharmaceutical giant Novo Nordisk ( NVO -4.99%) were lower by 4% as of 11 a.m. ET today. The move comes as the fallout from the sudden termination of its partnership with telehealth company Hims & Hers continues to escalate.

Barron's on MSN · 1d

Novo Nordisk Stock Drops on Weight-Loss Data. Why Investors Have Doubts.

Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled as the results missed investors’ expectations and reignited concerns about Novo’s rivalry with Eli Lilly.

Reuters on MSN · 1d

Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly's Mounjaro

By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Danish drugmaker Novo Nordisk launched its blockbuster weight-loss drug Wegovy in the world's most populous nation, in a move that will challenge rival Eli Lilly's Mounjaro,

2don MSN

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

4h

Novo Nordisk split puts Hims & Hers future in question

Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to ...

Novo Nordisk, seen as lagging in obesity drug race, says it’s playing the long game

Novo Nordisk is seen as having fallen behind in the race for new obesity drugs. It argues it is playing the long game.

1d

Novo Seeks Deals to Reverse Slide in Weight-Loss Market It Made

Novo Nordisk A/S is hunting for more early-stage deals to pad its pipeline of next-generation obesity drugs, as the drugmaker ...

1don MSN

Experimental drug helps patients lose nearly a quarter of body weight in early trials

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

Full data on Novo Nordisk’s new amylin drug raise dosing questions

Results for weight-loss drug targeting amylin find similar efficacy across different doses and high rates of side effects, ...

4don MSN

China's Sciwind's GLP-1 shows similar weight loss to Novo's Wegovy, study finds

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results